RAC 3.61% $1.47 race oncology ltd

Speculative M&A Transaction Analysis, page-848

  1. 1,269 Posts.
    lightbulb Created with Sketch. 12409
    They are fully funded for P2 CPACS which has a high chance of accelerated approval and peak global annual sales of $7b USD on 50% reduction to stated uptake.

    Stage IV asset typically get 5x peak sales.

    Honestly, man, do the maths.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.47
Change
-0.055(3.61%)
Mkt cap ! $250.5M
Open High Low Value Volume
$1.53 $1.58 $1.46 $143.9K 96.36K

Buyers (Bids)

No. Vol. Price($)
1 230 $1.47
 

Sellers (Offers)

Price($) Vol. No.
$1.48 550 1
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.